Insider Trades72 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | Sell | HOLX | Anne M. Liddy | General Counsel | 185 | $75.36 | $17.0B | -0.08% | +46.45% | $13.9K | -0.66% | — | Stalk |
| Feb 10, 2026 | Sell | HOLX | Mark W. Horvath | President, Breast & Skeletal | 113 | $75.15 | $17.0B | -0.08% | +46.45% | $8.5K | -0.49% | — | Stalk |
| Jan 30, 2026 | Sell | HOLX | Walt Diana De | SVP, Human Resources | 4,416 | $74.93 | $17.0B | -0.08% | +46.45% | $330.9K | -36.74% | — | Stalk |
| Jan 30, 2026 | Sell | HOLX | Walt Diana De | SVP, Human Resources | 4,416 | $74.93 | $17.0B | -0.08% | +46.45% | $330.9K | -36.74% | — | Stalk |
| Dec 12, 2025 | Sell | HOLX | Brandon Schnittker | President, GYN Surgical | 90 | $75.00 | $17.0B | -0.08% | +46.45% | $6.8K | -0.51% | — | Stalk |
| Nov 14, 2025 | Sell | HOLX | Brandon Schnittker | President, GYN Surgical | 178 | $74.15 | $17.0B | -0.08% | +46.45% | $13.2K | -1.00% | — | Stalk |
| Nov 14, 2025 | Sell | HOLX | Benjamin Jordan Cohn | Principal Accounting Officer | 187 | $74.15 | $17.0B | -0.08% | +46.45% | $13.9K | -1.03% | — | Stalk |
| Nov 14, 2025 | Sell | HOLX | Jan Verstreken | Group President, International | 196 | $74.15 | $17.0B | -0.08% | +46.45% | $14.5K | -0.15% | — | Stalk |
| Nov 14, 2025 | Sell | HOLX | Anne M. Liddy | General Counsel | 337 | $74.15 | $17.0B | -0.08% | +46.45% | $25.0K | -1.18% | — | Stalk |
| Nov 14, 2025 | Sell | HOLX | Jennifer M Schneiders | President, Diag. Solutions | 561 | $74.15 | $17.0B | -0.08% | +46.45% | $41.6K | -1.34% | — | Stalk |
| Nov 14, 2025 | Sell | HOLX | Karleen Marie Oberton | Chief Financial Officer | 1,333 | $74.15 | $17.0B | -0.08% | +46.45% | $98.8K | -0.88% | — | Stalk |
| Nov 14, 2025 | Sell | HOLX | Essex D Mitchell | Chief Operating Officer | 1,342 | $74.15 | $17.0B | -0.08% | +46.45% | $99.5K | -1.70% | — | Stalk |
| Nov 14, 2025 | Sell | HOLX | Stephen P Macmillan | Chairman, President and CEO | 6,874 | $74.15 | $17.0B | -0.08% | +46.45% | $509.7K | -0.48% | — | Stalk |
| Nov 7, 2025 | Sell | HOLX | Brandon Schnittker | President, GYN Surgical | 427 | $74.44 | $17.0B | -0.08% | +46.45% | $31.8K | -1.77% | — | Stalk |
| Nov 7, 2025 | Sell | HOLX | Anne M. Liddy | General Counsel | 694 | $74.39 | $17.0B | -0.08% | +46.45% | $51.6K | -1.70% | — | Stalk |
| Nov 7, 2025 | Sell | HOLX | Jennifer M Schneiders | President, Diag. Solutions | 860 | $74.51 | $17.0B | -0.08% | +46.45% | $64.1K | -1.56% | — | Stalk |
| Nov 7, 2025 | Sell | HOLX | Benjamin Jordan Cohn | Principal Accounting Officer | 1,259 | $74.17 | $17.0B | -0.08% | +46.45% | $93.4K | -3.87% | — | Stalk |
| Nov 7, 2025 | Sell | HOLX | Jan Verstreken | Group President, International | 1,598 | $74.16 | $17.0B | -0.08% | +46.45% | $118.5K | -0.63% | — | Stalk |
| Nov 7, 2025 | Sell | HOLX | Essex D Mitchell | Chief Operating Officer | 5,628 | $74.25 | $17.0B | -0.08% | +46.45% | $417.9K | -4.76% | — | Stalk |
| Nov 7, 2025 | Sell | HOLX | Karleen Marie Oberton | Chief Financial Officer | 10,876 | $74.17 | $17.0B | -0.08% | +46.45% | $806.6K | -3.99% | — | Stalk |
| Nov 7, 2025 | Sell | HOLX | Stephen P Macmillan | Chairman, President and CEO | 57,084 | $74.16 | $17.0B | -0.08% | +46.45% | $4.2M | -2.07% | — | Stalk |
| Sep 22, 2025 | Sell | HOLX | Stephen P Macmillan | Chairman, President and CEO | 276,716 | $53.47 | $17.0B | -0.08% | +46.45% | $14.8M | +0.00% | — | Stalk |
| May 30, 2025 | Sell | HOLX | Brandon Schnittker | Div. President, GYN Surgical | 69 | $62.17 | $17.0B | -0.08% | +46.45% | $4.3K | -1.12% | — | Stalk |
| Dec 13, 2024 | Sell | HOLX | Brandon Schnittker | Div. President, GYN Surgical | 90 | $73.65 | $17.0B | -0.08% | +46.45% | $6.6K | -1.44% | — | Stalk |
| Dec 4, 2024 | Sell | HOLX | Essex D Mitchell | Chief Operating Officer | 47,758 | $69.75 | $17.0B | -0.08% | +46.45% | $3.3M | -0.99% | — | Stalk |
| Nov 14, 2024 | Sell | HOLX | Benjamin Jordan Cohn | Principal Accounting Officer | 110 | $77.54 | $17.0B | -0.08% | +46.45% | $8.5K | -0.97% | — | Stalk |
| Nov 14, 2024 | Sell | HOLX | Brandon Schnittker | Div. President, GYN Surgical | 178 | $77.54 | $17.0B | -0.08% | +46.45% | $13.8K | -2.77% | — | Stalk |
| Nov 14, 2024 | Sell | HOLX | Erik S Anderson | Div. Pres., Breast & Skeletal | 390 | $77.54 | $17.0B | -0.08% | +46.45% | $30.2K | -1.65% | — | Stalk |
| Nov 14, 2024 | Sell | HOLX | Jennifer M Schneiders | President, Diag. Solutions | 507 | $77.54 | $17.0B | -0.08% | +46.45% | $39.3K | -4.02% | — | Stalk |
| Nov 14, 2024 | Sell | HOLX | Jan Verstreken | Group President, International | 630 | $77.54 | $17.0B | -0.08% | +46.45% | $48.9K | -0.60% | — | Stalk |
| Nov 14, 2024 | Sell | HOLX | John M. Griffin | General Counsel | 1,120 | $77.54 | $17.0B | -0.08% | +46.45% | $86.8K | -0.61% | — | Stalk |
| Nov 14, 2024 | Sell | HOLX | Karleen Marie Oberton | Chief Financial Officer | 1,332 | $77.54 | $17.0B | -0.08% | +46.45% | $103.3K | -1.29% | — | Stalk |
| Nov 14, 2024 | Sell | HOLX | Essex D Mitchell | Chief Operating Officer | 1,341 | $77.54 | $17.0B | -0.08% | +46.45% | $104.0K | -4.29% | — | Stalk |
| Nov 14, 2024 | Sell | HOLX | Stephen P Macmillan | Chairman, President and CEO | 6,860 | $77.54 | $17.0B | -0.08% | +46.45% | $531.9K | -0.55% | — | Stalk |
| Nov 7, 2024 | Sell | HOLX | Brandon Schnittker | Div. President, GYN Surgical | 138 | $79.29 | $17.0B | -0.08% | +46.45% | $10.9K | -1.14% | — | Stalk |
| Nov 7, 2024 | Sell | HOLX | Jennifer M Schneiders | President, Diag. Solutions | 282 | $79.06 | $17.0B | -0.08% | +46.45% | $22.3K | -0.89% | — | Stalk |
| Nov 7, 2024 | Sell | HOLX | Benjamin Jordan Cohn | Principal Accounting Officer | 296 | $78.95 | $17.0B | -0.08% | +46.45% | $23.4K | -1.22% | — | Stalk |
| Nov 7, 2024 | Sell | HOLX | Erik S Anderson | Div. Pres., Breast & Skeletal | 1,741 | $78.86 | $17.0B | -0.08% | +46.45% | $137.3K | -3.17% | — | Stalk |
| Nov 7, 2024 | Sell | HOLX | Essex D Mitchell | Chief Operating Officer | 4,805 | $78.81 | $17.0B | -0.08% | +46.45% | $378.7K | -5.83% | — | Stalk |
| Nov 7, 2024 | Sell | HOLX | Jan Verstreken | Group President, International | 5,529 | $78.82 | $17.0B | -0.08% | +46.45% | $435.8K | -2.45% | — | Stalk |
| Nov 7, 2024 | Sell | HOLX | John M. Griffin | General Counsel | 9,891 | $78.79 | $17.0B | -0.08% | +46.45% | $779.3K | -2.52% | — | Stalk |
| Nov 7, 2024 | Sell | HOLX | Karleen Marie Oberton | Chief Financial Officer | 13,759 | $78.80 | $17.0B | -0.08% | +46.45% | $1.1M | -5.68% | — | Stalk |
| Nov 7, 2024 | Sell | HOLX | Stephen P Macmillan | Chairman, President and CEO | 74,661 | $78.80 | $17.0B | -0.08% | +46.45% | $5.9M | -2.80% | — | Stalk |
| Aug 29, 2024 | Sell | HOLX | Karleen Marie Oberton | Chief Financial Officer | 85,484 | $65.36 | $17.0B | -0.08% | +46.45% | $5.6M | -5.36% | — | Stalk |
| Aug 6, 2024 | Sell | HOLX | Brandon Schnittker | Div. President, GYN Surgical | 476 | $83.11 | $17.0B | -0.08% | +46.45% | $39.6K | -11.30% | — | Stalk |
| Aug 1, 2024 | Sell | HOLX | Benjamin Jordan Cohn | Principal Accounting Officer | 5,093 | $81.99 | $17.0B | -0.08% | +46.45% | $417.6K | -32.71% | — | Stalk |
| Jul 30, 2024 | Sell | HOLX | Stephen P Macmillan | Chairman, President and CEO | 88,078 | $53.95 | $17.0B | -0.08% | +46.45% | $4.8M | +0.00% | — | Stalk |
| Jul 17, 2024 | Sell | HOLX | Stephen P Macmillan | Chairman, President and CEO | 7,344 | $53.17 | $17.0B | -0.08% | +46.45% | $390.5K | +0.00% | — | Stalk |
| May 31, 2024 | Sell | HOLX | Brandon Schnittker | Div. President, GYN Surgical | 67 | $73.78 | $17.0B | -0.08% | +46.45% | $4.9K | -1.57% | — | Stalk |
| May 23, 2024 | Sell | HOLX | Stephen P Macmillan | Chairman, President and CEO | 57,875 | $73.99 | $17.0B | -0.08% | +46.45% | $4.3M | -4.76% | — | Stalk |
| Apr 19, 2024 | Sell | HOLX | Stephen P Macmillan | Chairman, President and CEO | 24,000 | $75.38 | $17.0B | -0.08% | +46.45% | $1.8M | -0.97% | — | Stalk |
| Jan 29, 2024 | Sell | HOLX | Karleen Marie Oberton | Chief Financial Officer | 14,940 | $75.00 | $17.0B | -0.08% | +46.45% | $1.1M | -12.57% | — | Stalk |
| Nov 29, 2023 | Sell | HOLX | Stephen P Macmillan | Chairman, President and CEO | 95,422 | $48.31 | $17.0B | -0.08% | +46.45% | $4.6M | +0.00% | — | Stalk |
| Nov 21, 2023 | Sell | HOLX | Essex D Mitchell | Div. President, GYN Surgical | 7,500 | $71.85 | $17.0B | -0.08% | +46.45% | $538.9K | -36.90% | — | Stalk |
| Nov 8, 2023 | Sell | HOLX | Jennifer M Schneiders | President, Diag. Solutions | 295 | $67.64 | $17.0B | -0.08% | +46.45% | $20.0K | -4.76% | — | Stalk |
| Nov 8, 2023 | Sell | HOLX | Benjamin Jordan Cohn | Principal Accounting Officer | 407 | $67.70 | $17.0B | -0.08% | +46.45% | $27.6K | -1.42% | — | Stalk |
| Nov 8, 2023 | Sell | HOLX | Elisabeth A Hellmann | SVP, Human Resources | 438 | $67.80 | $17.0B | -0.08% | +46.45% | $29.7K | -2.58% | — | Stalk |
| Nov 8, 2023 | Sell | HOLX | Erik S Anderson | Div. Pres., Breast & Skeletal | 1,565 | $67.29 | $17.0B | -0.08% | +46.45% | $105.3K | -5.52% | — | Stalk |
| Nov 8, 2023 | Sell | HOLX | Jan Verstreken | Group President, International | 1,672 | $67.32 | $17.0B | -0.08% | +46.45% | $112.6K | -1.04% | — | Stalk |
| Nov 8, 2023 | Sell | HOLX | Essex D Mitchell | Div. President, GYN Surgical | 2,635 | $67.34 | $17.0B | -0.08% | +46.45% | $177.4K | -9.34% | — | Stalk |
| Nov 8, 2023 | Sell | HOLX | John M. Griffin | General Counsel | 9,977 | $67.26 | $17.0B | -0.08% | +46.45% | $671.1K | -2.95% | — | Stalk |
| Nov 8, 2023 | Sell | HOLX | Karleen Marie Oberton | Chief Financial Officer | 11,587 | $67.26 | $17.0B | -0.08% | +46.45% | $779.4K | -4.77% | — | Stalk |
| Nov 8, 2023 | Sell | HOLX | Stephen P Macmillan | Chairman, President and CEO | 71,253 | $67.28 | $17.0B | -0.08% | +46.45% | $4.8M | -2.81% | — | Stalk |
| Nov 7, 2023 | Sell | HOLX | Benjamin Jordan Cohn | Principal Accounting Officer | 106 | $68.37 | $17.0B | -0.08% | +46.45% | $7.2K | -0.73% | — | Stalk |
| Nov 7, 2023 | Sell | HOLX | Jennifer M Schneiders | President, Diag. Solutions | 154 | $68.37 | $17.0B | -0.08% | +46.45% | $10.5K | -4.65% | — | Stalk |
| Nov 7, 2023 | Sell | HOLX | Jan Verstreken | Group President, International | 247 | $68.37 | $17.0B | -0.08% | +46.45% | $16.9K | -0.31% | — | Stalk |
| Nov 7, 2023 | Sell | HOLX | Elisabeth A Hellmann | SVP, Human Resources | 272 | $68.37 | $17.0B | -0.08% | +46.45% | $18.6K | -3.06% | — | Stalk |
| Nov 7, 2023 | Sell | HOLX | Erik S Anderson | Div. Pres., Breast & Skeletal | 343 | $68.37 | $17.0B | -0.08% | +46.45% | $23.5K | -3.07% | — | Stalk |
| Nov 7, 2023 | Sell | HOLX | Essex D Mitchell | Div. President, GYN Surgical | 384 | $68.37 | $17.0B | -0.08% | +46.45% | $26.3K | -4.36% | — | Stalk |
| Nov 7, 2023 | Sell | HOLX | John M. Griffin | General Counsel | 592 | $68.37 | $17.0B | -0.08% | +46.45% | $40.5K | -0.35% | — | Stalk |
| Nov 7, 2023 | Sell | HOLX | Karleen Marie Oberton | Chief Financial Officer | 740 | $68.37 | $17.0B | -0.08% | +46.45% | $50.6K | -0.60% | — | Stalk |
| Nov 7, 2023 | Sell | HOLX | Stephen P Macmillan | Chairman, President and CEO | 3,974 | $68.37 | $17.0B | -0.08% | +46.45% | $271.7K | -0.31% | — | Stalk |